arrow
Back
K

Kenji P. Fujita

Autonomous University of Madrid

17H-index
37Paper Count
2.1KCitation Count
Published Papers 10
Publication Date
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children
err2022-03-01
err44
errOAAI
errSas, David J.; Magen, Daniella; Hayes, Wesley; Shasha-Lavsky, Hadas; Michael, Mini; Schulte, Indra; Sellier-Leclerc, Anne-Laure; Lu, Jiandong; Seddighzadeh, Ali; Habtemariam, Bahru; McGregor, Tracy L.; Fujita, Kenji P.; Frishberg, Yaacov
errShare
errSave
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
err2021-01-26
err50
errOAAI
errMantegazza, Renato; Wolfe, Gil, I; Muppidi, Srikanth; Wiendl, Heinz; Fujita, Kenji P.; O'Brien, Fanny L.; Booth, Heather D. E.; Howard, James F., Jr.
errShare
errSave
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
err2019-12-01
err15
errOAAI
errMurai, Hiroyuki; Uzawa, Akiyuki; Suzuki, Yasushi; Imai, Tomihiro; Shiraishi, Hirokazu; Suzuki, Hidekazu; Okumura, Meinoshin; O'Brien, Fanny; Wang, Jing-Jing; Fujita, Kenji P.; Utsugisawa, Kimiaki
errShare
errSave
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
err2019-08-15
err517
errOAAI
errPittock, S. J.; Berthele, A.; Fujihara, K.; Kim, H. J.; Levy, M.; Palace, J.; Nakashima, I.; Terzi, M.; Totolyan, N.; Viswanathan, S.; Wang, K. -C.; Pace, A.; Fujita, K. P.; Armstrong, R.; Wingerchuk, D. M.
errShare
errSave
Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study
err2019-06-01
err47
errOAAI
errWhyte, Michael P.; Leung, Edward; Wilcox, William R.; Liese, Johannes; Argente, Jesus; Martos-Moreno, Gabriel A.; Reeves, Amy; Fujita, Kenji P.; Moseley, Scott; Hofmann, Christine; Beck, Michael; DiMeglio, Linda; Hwu, Paul Wuh-Liang; Madson, Katherine L.; Nanda, Upasana; Simm, Peter; Simmons, Jill; Steelman, Joel; Steiner, Robert D.; Superti-Furga, Andrea
errShare
errSave
Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study
err2019-02-27
err60
errOAAI
errHofmann, Christine E.; Harmatz, Paul; Vockley, Jerry; Hoegler, Wolfgang; Nakayama, Hideki; Bishop, Nick; Martos-Moreno, Gabriel A.; Moseley, Scott; Fujita, Kenji P.; Liese, Johannes; Rockman-Greenberg, Cheryl
errShare
errSave
Asfotase alfa therapy for children with hypophosphatasia
err2016-06-16
err146
errOAAI
errWhyte, Michael P.; Madson, Katherine L.; Phillips, Dawn; Reeves, Amy L.; McAlister, William H.; Yakimoski, Amy; Mack, Karen E.; Hamilton, Kim; Kagan, Kori; Fujita, Kenji P.; Thompson, David D.; Moseley, Scott; Odrljin, Tatjana; Rockman-Greenberg, Cheryl
errShare
errSave
Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function
err2014-01-13
err11
errOAAI
errPonikowski, Piotr; Mitrovic, Veselin; O'Connor, Christopher M.; Dittrich, Howard; Cotter, Gad; Massie, Barry M.; Givertz, Michael M.; Chen, Erluo; Murray, Meredith; Weatherley, Beth D.; Fujita, Kenji P.; Metra, Marco
errShare
errSave
Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure Analysis From the PROTECT Pilot Study
err2011-11-01
err76
errOAAI
errO'Connor, Christopher M.; Fiuzat, Mona; Lombardi, Carlo; Fujita, Kenji; Jia, Gang; Davison, Beth A.; Cleland, John; Bloomfield, Daniel; Dittrich, Howard C.; DeLucca, Paul; Givertz, Michael M.; Mansoor, George; Ponikowski, Piotr; Teerlink, John R.; Voors, Adriaan A.; Massie, Barry M.; Cotter, Gad; Metra, Marco
errShare
errSave